FDA.reportPublic FDA data

brivaracetam 25 MG Oral Tablet [Briviact]

RxCUI
1739774
RxNorm name
brivaracetam 25 MG Oral Tablet [Briviact]
Display name
brivaracetam 25 MG Oral Tablet [Briviact]
Full name
brivaracetam 25 MG Oral Tablet [Briviact]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BriviactBRIVARACETAMUCB, Inc.3cf2f439-0e97-443e-8e33-25ecef616f6c2026-08-20Warnings, Adverse reactionsExact identifier
rxcui: 1739774

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3cf2f439-0e97-443e-8e33-25ecef616f6cBriviact 25 MG Oral Tablet [PSN] · brivaracetam 25 MG Oral Tablet [Briviact] [SBD] · Briviact 25 MG Oral Tablet [SY]326These highlights do not include all the information needed to use BRIVIACT ® safely and effectively. See full prescribing information for BRIVIACT. BRIVIACT ® (brivaracetam) tablets, for oral use, CV BRIVIACT ® (brivaracetam) oral solution, CV BRIVIACT ® (brivaracetam) injection, for intravenous use, CV Initial U.S. Approval: 201620260513